The predictors of lymphopenia and its effects on survival in locally advanced esophageal squamous cell carcinoma

The predictors of lymphopenia and its effects on survival in locally advanced esophageal squamous cell carcinoma

To investigate the impact of the effective radiation dose to immune cells (EDIC) and gross tumor volume (GTV) on lymphopenia and survival in patients with locally advanced esophageal squamous cell carcinoma (LAESCC). Between January 2013 and December 2020, 272 LAESCC patients were treated with defin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Danjing Luo, Qiulu Zhong, Haiying Yue, Jue Wang, Qianfu Liang, Wenqi Liu, Xiaodong Zhu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Cancer Biology & Therapy
Subjects:	Lymphopenia the effective radiation dose to immune cells esophageal squamous cell carcinoma definitive radiation therapy gross tumor volume survival
Online Access:	https://www.tandfonline.com/doi/10.1080/15384047.2024.2371632
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification of dosimetric risk factors associated to lymphopenia in brain metastases patients with radiotherapy
by: Sujie Zhang, et al.
Published: (2025-07-01)

Research Development of Radiation-Induced Lymphopenia
by: Yue WANG, et al.
Published: (2025-04-01)

Influence of Local Tumor Factors and Radiotherapy Dose on Prognosis of Clinical Stage T1-4N0M0 Esophageal Squamous Cell Carcinoma
by: Yan KONG, et al.
Published: (2025-03-01)

Development and validation a radiomics combined clinical model predicts treatment response for esophageal squamous cell carcinoma patients
by: Xiaoyan Yin, et al.
Published: (2025-04-01)

Sequencing of chemotherapy in total neoadjuvant treatment for rectal cancer does not predict radiation-induced lymphopenia
by: Orazem Miha, et al.
Published: (2025-06-01)

Prognostic Value of Radiation-Induced Lymphopenia in Patients with Unresectable Primary Hepatocellular Carcinoma Receiving Radiotherapy
by: Jinlong TONG, et al.
Published: (2024-12-01)

Impact of radiation dose to immune cells on survival in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a retrospective analysis
by: Junfeng Zhao, et al.
Published: (2025-02-01)

LYMPHOPENIA: THE MAIN CAUSES
by: N. T. Vatutin, et al.
Published: (2016-05-01)

Associations of peripheral blood lymphopenia to disease course, treatment and TNF-α in sarcoidosis
by: Avinash Padhi, et al.
Published: (2025-04-01)

A CT-based subregional radiomics nomogram for predicting local recurrence-free survival in esophageal squamous cell cancer patients treated by definitive chemoradiotherapy: a multicenter study
by: Jie Gong, et al.
Published: (2024-12-01)

Dental status of patients with squamous cell carcinoma of the oropharyngeal region
by: A. M. Avanesov, et al.
Published: (2019-12-01)

Detecting radiation esophagitis using 18F-FAPI-04 PET/CT in patients with LA-ESCC treated with concurrent chemoradiotherapy
by: Xinying Hu, et al.
Published: (2025-05-01)

The Role of Lymphocyte Recovery Index in Prognosis Prediction for Locally Advanced Cervical Cancer With Radiation‐Induced Lymphopenia
by: Yi Li, et al.
Published: (2025-02-01)

Clinical outcomes of esophageal squamous cell carcinoma in patients aged over 80 years
by: Dae Gon Ryu, et al.
Published: (2025-03-01)

A case of long-term survival after surgical resection for solitary adrenal recurrence of esophageal squamous carcinoma
by: Nobuhiko Kanaya, et al.
Published: (2017-05-01)

Enabling immune checkpoint blockade efficacy in T-lymphopenia by restoring CD8 T cell dynamics with IL-7 cytokine therapy
by: Yeon-Woo Kang, et al.
Published: (2024-12-01)

Neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma: does everyone need it?
by: D. A. Chichevatov, et al.
Published: (2024-05-01)

The role of squamous cell carcinoma antigen and cytokeratin 19 fragment in predicting the outcome of esophageal cancer patients: insights from a meta-analysis
by: Xiaojiang Zhou, et al.
Published: (2025-04-01)

Characteristics of Esophageal Squamous Cell Carcinomas Based on Circumferential Localization
by: Natsuki Ishida, et al.
Published: (2024-12-01)

Incidence trends of esophageal squamous cell and adenocarcinoma in Finland in 2000–2021
by: Pietari Junkala, et al.
Published: (2025-08-01)

Endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in patients with cirrhosis and esophageal varices
by: Tomoaki Mochimaru, et al.
Published: (2023-04-01)

Research Status and Progress on Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma in Hebei Province
by: Xiaoyang DUAN, et al.
Published: (2025-02-01)

CT-radiomics combined with inflammatory indicators for prediction of progression free survival of resectable esophageal squamous cell carcinoma
by: Yating Wang, et al.
Published: (2025-05-01)

Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China
by: Shu Huang, et al.
Published: (2025-02-01)

Survival outcome prediction of esophageal squamous cell carcinoma patients based on radiomics and mutation signature
by: Ting Yan, et al.
Published: (2025-01-01)

Giant esophageal liposarcoma with squamous cell carcinoma resected via the cervical approach: a case report
by: Tomohiro Okura, et al.
Published: (2022-06-01)

Metabolic state uncovers prognosis insights of esophageal squamous cell carcinoma patients
by: Tingze Feng, et al.
Published: (2025-03-01)

The efficacy of neoadjuvant immunotherapy and lymphocyte subset predictors in locally advanced esophageal squamous cell carcinoma: A retrospective study
by: Ruotong Wang, et al.
Published: (2024-09-01)

Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma
by: Xiaqin Zhang, et al.
Published: (2025-01-01)

Anlotinib plus camrelizumab and chemotherapy as first-line treatment in patients with advanced esophageal squamous cell carcinoma
by: Mingfang Xu, et al.
Published: (2025-07-01)

Immunotherapy in advanced esophageal squamous cell cancer: earlier or later?
by: Shuang Wei, et al.
Published: (2025-07-01)

The intratumoral landscape of T cell receptor repertoire in esophageal squamous cell carcinoma
by: Meng Yang, et al.
Published: (2024-11-01)

Unveiling SSR4: a promising biomarker in esophageal squamous cell carcinoma
by: Jiaqi Zhang, et al.
Published: (2025-02-01)

Advancing precision medicine in esophageal squamous cell carcinoma using patient-derived organoids
by: Suya Shen, et al.
Published: (2024-12-01)

Prognostic prediction and diagnostic role of Rspondin 1 expression in esophageal squamous cell carcinoma
by: Xiaoxia Cheng, et al.
Published: (2025-01-01)

Circulating Tumor DNA Dynamic Changes in Esophageal Squamous Cell Carcinoma Receiving Immunochemotherapy
by: Yijia Guo, et al.
Published: (2025-05-01)

Current strategy of squamous cell carcinoma diagnosis and treatment
by: A. P. Polyakov, et al.
Published: (2021-04-01)

Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma
by: Qing Liu, et al.
Published: (2024-08-01)

Expression of kinetochore component NDC80 promotes esophageal squamous cell carcinoma cells proliferation and migration
by: Youwu Shi, et al.
Published: (2025-06-01)

Integrative analysis of saliva-derived exosomal proteome and lipidome for the diagnosis of esophageal squamous cell carcinoma
by: Wei Zhong, et al.
Published: (2025-08-01)